The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Spodumene Concentrate (6%, CIF China)
Price: $1,076.00
1 day: $-7.0 (-0.65%)
Kodal investment program is built on spodumene price of $2080/t so very far from todays $1076
Spodumene Concentrate (6%, CIF China)
Price: $1,076.00
1 day: $-7.0 (-0.65%)
YTD: -18.17%
Not Acker
Its beyond stupid think they have work part on Easter Sunday
Spodumene Price $1083 - unchanged
Not Acker
These interview are getting worse and worse. Roach cant explain in detail what they need to do to get to nameplate capacity.
He is still suggesting nonsense about non-equity finance, well its only a couple of month ago Roach claimed that they could get bank financing when the plant start and then we 15th Feb, boom, new placing.
My prediction, new placing in the next few week and before then RNS that they failed to deliver March volume to Canmax
Furthermore, on the Williston valuation, if you look at Lucero Energy (pure play on Williston), their enterprise value is $250m and they are producing app 10000 boepd and have over 43m barrels of 1P reserves. If you use this as a peer for Zephyr, their Williston asset would only be valued to $20-25m.
Candlestick,
The market cap is £48m at 3p not $48m. So market cap in $61m. Giving you EV of $86m. Which gives residual value of Paradox of $21m.
No update from HUM, I guess Corica Mining Services is not back working. Another down day
Looks cheap
https://twitter.com/OilGasTracker/status/1769762657068867862
Stifel has raised its rating on DGI9 to buy from hold today. Expect shareholder to get at least 40p from wind down in the near-medium term future and then possible value from Arqiva on top of that.
8.8m new shares issued, looks to me that they are issued at 24.5p, big discount to the current price.
Https://twitter.com/StockBoxMedia/status/1767872579132424396
No other words needed
Its now been 13 days since the last RNS, where the company wrote that the plant has started up but with a few start-up problems. The main problem seem to have be that the dosing system is "unable adjust pH to design specifications", but as Mr Roach said in interview the following day, 1 March, that these issue would be resolved in few days.
The company also wrote in the RNS that "Analysis of the concentrates is underway." and Mr Roach said in the following interview that they would have the result in the next few days.
Tomorrow 2 weeks has passed since the above RNS, and there has not been a word on the start-up issues and no word on the analysis of the concentrate.
I'm really starting to wonder what is going on?
This looks pretty bad.
It would have been nice if they could have reported the last quarter production.
If it was insignificant, why even mention it?
This looks odd
https://twitter.com/OilGasTracker/status/1767095839451763084
Does anyone know where I can find the bond prospectus?
Thanks
In today's RNS they are writing "No performance guarantees are required to be posted in relation to this contract", which makes it sounds like if there had been performance guarantees involved they would struggle to sign the contract.
Petrofac really need to complete the "strengthening" of the balance sheet process before it damaging the business to much.